Tema Obesity & Cardiometabolic ETF Rating $29.02 +0.42 (+1.47%) As of 05/2/2025 03:18 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsRatingsBuy This Stock Tema Obesity & Cardiometabolic ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.HRTS Aggregate RatingModerate Buy 2.79Holdings in HRTS have an aggregate rating of Moderate Buy based on 642 analyst ratings issued in the past year covering 38 companies (83.8% of the portfolio).HRTS Aggregate Price Target$29.02High Prediction$29.02Average Prediction$29.02Low Prediction$29.02Holdings in HRTS have an aggregate price target of $29.02 and a range of $29.02 to $29.02 covering 38 companies (83.8% of the portfolio).HRTS Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy9 Buy rating(s)Moderate Buy24 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Tema Obesity & Cardiometabolic ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 38 HRTS Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings11.03%LLYEli Lilly and Company$825.10+3.9%4.9236 of 5 stars2.81$1,002.80 21.5%21Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGap Up4.83%UNHUnitedHealth Group$398.72-0.5%4.9539 of 5 stars2.92$596.86 49.7%24Analyst ForecastOptions VolumeAnalyst RevisionHigh Trading Volume4.09%ABTAbbott Laboratories$132.92+1.6%4.9069 of 5 stars2.84$142.59 7.3%19Insider TradePositive News3.86%RHHBYRoche$41.08+3.8%N/A2.388Short Interest ↑Gap Up3.54%VRTXVertex Pharmaceuticals$501.15+0.5%3.9668 of 5 stars2.64$514.91 2.7%25Upcoming EarningsPositive News3.16%BSXBoston Scientific$104.94+1.7%4.1406 of 5 stars3.04$114.52 9.1%23Analyst UpgradeNews CoveragePositive News2.96%BBIOBridgeBio Pharma$38.57+0.4%4.6199 of 5 stars2.92$57.09 48.0%12Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage2.94%GILDGilead Sciences$103.68+0.4%4.8989 of 5 stars2.78$110.55 6.6%27Dividend AnnouncementPositive News2.92%CRNXCrinetics Pharmaceuticals$33.76+0.7%3.7899 of 5 stars2.92$73.00 116.2%13Upcoming EarningsNews CoveragePositive News2.91%MDTMedtronic$84.74+1.4%4.5196 of 5 stars2.44$96.14 13.5%16Positive News2.67%TMOThermo Fisher Scientific$423.69+0.9%4.8799 of 5 stars2.81$607.43 43.4%21Analyst ForecastInsider TradeShort Interest ↑Positive NewsGap Up2.58%MRKMerck & Co., Inc.$83.14-0.1%5 of 5 stars2.59$111.13 33.7%22Insider TradeAnalyst RevisionPositive News2.28%ABBVAbbVie$198.62+2.7%4.6128 of 5 stars2.89$211.41 6.4%27Earnings ReportAnalyst ForecastAnalyst RevisionPositive News2.27%CYTKCytokinetics$37.35-13.0%4.0524 of 5 stars2.89$76.88 105.8%19Upcoming EarningsAnalyst ForecastInsider TradeOptions VolumeNews CoverageGap DownHigh Trading Volume2.13%BMYBristol-Myers Squibb$50.56+1.9%4.7101 of 5 stars2.32$58.00 14.7%22Insider TradeAnalyst Revision2.13%EWEdwards Lifesciences$75.57+0.5%4.6282 of 5 stars2.42$79.45 5.1%24Short Interest ↓Positive News2.00%DHRDanaher$199.15+1.2%4.9422 of 5 stars2.80$264.40 32.8%20Insider TradeShort Interest ↑News CoveragePositive NewsGap Up1.89%MCKMcKesson$707.28+0.1%4.4008 of 5 stars2.88$681.00 -3.7%16Upcoming EarningsDividend AnnouncementAnalyst ForecastPositive News1.85%REGNRegeneron Pharmaceuticals$605.61+2.6%4.8382 of 5 stars2.88$892.60 47.4%26Earnings ReportDividend AnnouncementAnalyst ForecastAnalyst RevisionNews CoverageHigh Trading Volume1.75%PODDInsulet$257.01+2.7%4.5628 of 5 stars2.76$293.94 14.4%17Upcoming EarningsAnalyst DowngradeNews CoveragePositive News1.74%AMGNAmgen$281.22-0.9%4.1049 of 5 stars2.41$308.18 9.6%22Earnings ReportAnalyst ForecastAnalyst RevisionNews CoveragePositive NewsGap Up1.72%ASNDAscendis Pharma A/S$172.06+2.7%2.3442 of 5 stars2.93$211.40 22.9%15Earnings ReportAnalyst ForecastAnalyst RevisionNews CoveragePositive NewsHigh Trading Volume1.66%MREOMereo BioPharma Group$2.67+2.7%2.3554 of 5 stars3.25$7.71 188.9%8News CoveragePositive News1.66%ALNYAlnylam Pharmaceuticals$259.39+1.7%4.1204 of 5 stars2.77$319.17 23.0%26Earnings ReportAnalyst DowngradeNews Coverage1.57%DXCMDexCom$81.62+16.2%4.7235 of 5 stars2.95$99.22 21.6%20Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGap UpHigh Trading Volume1.37%INSMInsmed$72.30-0.5%4.382 of 5 stars3.00$94.00 30.0%16Upcoming EarningsInsider TradeNews CoveragePositive News1.31%MDGLMadrigal Pharmaceuticals$315.48-3.7%4.5986 of 5 stars2.90$416.33 32.0%10Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.25%MASIMasimo$166.42+1.7%3.6773 of 5 stars2.83$194.80 17.1%6Upcoming Earnings1.15%IONSIonis Pharmaceuticals$32.78+3.4%4.3966 of 5 stars2.65$56.67 72.9%20Earnings ReportAnalyst ForecastInsider TradeNews CoveragePositive News1.15%GPCRStructure Therapeutics$27.09-0.9%2.4264 of 5 stars3.00$78.63 190.2%9Upcoming EarningsAnalyst ForecastNews CoverageGap Up1.07%VKTXViking Therapeutics$29.36+2.6%4.5331 of 5 stars3.00$87.15 196.8%14Analyst UpgradeOptions VolumeAnalyst RevisionGap Up0.93%ARWRArrowhead Pharmaceuticals$14.42+2.7%3.6203 of 5 stars2.60$41.44 187.4%10Positive News0.86%AKROAkero Therapeutics$44.87-1.0%3.8022 of 5 stars3.00$76.29 70.0%9Upcoming EarningsNews CoveragePositive News0.82%MIRMMirum Pharmaceuticals$43.69+0.6%4.2674 of 5 stars3.09$58.20 33.2%11Upcoming EarningsNews CoveragePositive News0.82%WSTWest Pharmaceutical Services$211.27+0.5%4.662 of 5 stars3.00$332.50 57.4%80.45%RCKTRocket Pharmaceuticals$8.01+1.9%4.7418 of 5 stars2.92$43.00 436.8%12Upcoming Earnings0.26%NTLAIntellia Therapeutics$8.84+2.3%4.614 of 5 stars2.65$36.68 315.0%20Upcoming Earnings0.25%MTSRMetsera$25.65+9.8%N/A3.00$47.00 83.2%4Gap Up This page (NYSEARCA:HRTS) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Obesity & Cardiometabolic ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Obesity & Cardiometabolic ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HRTS Stock Free HRTS Stock Alerts